中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 32 Issue 1
Jan.  2016
Turn off MathJax
Article Contents

Efficacy of prostaglandin E1 as adjuvant therapy for mild to moderate acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2016.01.023
Research funding:

 

  • Received Date: 2015-07-01
  • Published Date: 2016-01-20
  • Objective To observe the clinical effect and efficacy of prostaglandin E1( PGE1),the drug for microcirculation improvement,in the treatment of acute pancreatitis( AP). Methods A total of 80 patients with mild- to- moderate AP who were hospitalized and treated in Second Department of Hepatobiliary and Pancreatic Surgery of the First Hospital of Jilin University from May 2014 to January 2015 were enrolled and randomized into two groups. Forty- four patients in control group received the conventional comprehensive therapy for AP,and36 patients in experiment group received PGE1 in addition to the conventional therapy. The time to disappearance of abdominal symptoms and the time for serum and urine levels of amylase and serum levels of lipase,C- reactive protein( CRP),and procalcitonin( PCT) to return to normal were compared between the two groups. The independent- samples t- test was applied for comparison of continuous data between the two groups,and the chi- square test or Fisher's exact test was applied for comparison of categorical data between the two groups.Results The two groups had significant differences in the time for serum levels of amylase and CRP and percentage of neutrophils to return to normal and hospital costs( P = 0. 041,0. 030,0. 012,and 0. 026,respectively). PGE1 quickly relieved abdominal pain and distention,reduced the serum level of amylase,shortened the length of hospital stay,and reduced hospital costs. Conclusion PGE1 has good clinical effect and safety in the treatment of AP,and can be applied as an adjuvant drug in the comprehensive therapy for AP.

     

  • loading
  • [1]Pancreas Study Group,Chinese Society of Gastroenteroloy,Chinese Medical Association,Editorial Board of Chinese Journal of Pancreatolog,Editorial Board of Chinese Journal of Digestion.Chinese guidelines for the management of acute pancreatitis(Shanghai,2013)[J].J Clin Hepatol,2013,29(9):656-660.(in Chinese)中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编辑委员会,《中华消化杂志》编辑委员会.中国急性胰腺炎诊治指南(2013年,上海)[J].临床肝胆病杂志,2013,29(9):656-660.
    [2] Group of Pancreatic Surgery,Chinese Society of Surgery,Chinese Medical Association.Guidelines for the management of acute pancreatitis(2014)[J].J Clin Hepatol,2015,31(1):17-20.(in Chinese)中华医学会外科学分会胰腺外科学组.急性胰腺炎诊治指南(2014版)[J].临床肝胆病杂志,2015,31(1):17-20.
    [3]LIU DY,LEI LM,LIAO ZH,et al.Traditional Chinese medicine in treatment of acute pancreatitis[J].J Changchun Univ Tradit Chin Med,2015,31(4):877-880.(in Chinese)刘冬一,雷力民,廖昭海,等.中医药治疗急性胰腺炎研究进展[J].长春中医药大学学报,2015,31(4):877-880.
    [4]JIN C,NI QX,ZHANG QH,et al.The relationship between pancreatic ischemia and cytokines in rats with acute pancreatitis[J].Chin J Gen Surg,2001,16(11):662-664.(in Chinese)金忱,倪泉兴,张群华,等.急性胰腺炎时胰腺缺血与细胞因子相关性的实验研究[J].中华普通外科杂志,2001,16(11):662-664.
    [5]ZHANG LF,LI L,LI JC.Application of ameliorating microcirculation to treatment of severe pancreatitis[J].Chin J Pract Intern Med,2002,22(3):163-164.(in Chinese)张连峰,李丽,李继昌.改善微循环在重症胰腺炎治疗中的应用[J].中国实用内科杂志,2002,22(3):163-164.
    [6]YCEL K,ALHAN E,KCKTL U,et al.The effects of prostaglandin E1 on the microperfusion of the pancreas during acute necrotizingpancreatitis in rats[J].Hepatogastroenterology,2002,49(44):544-548.
    [7]BUSCAIL L,BUSSENOT I,BOUISSON M,et al.Protective effect of misoprostol,a synthetic prostaglandin E1 analog,on ceruleininduced acutepancreatitis in rats[J].Pancreas,1990,5(2):171-176.
    [8]CROCKET KV,BRACKETT K,CROCKET A,et al.Prostaglandin E1 treatment in experimental acute pancreatitis in the rat[J].Eur Surg Res,1984,16(5):265-273.
    [9]GUO XZ,WU CY.Pay attention to the relationship between etiology and diagnosis of acute pancreatitis[J].Chin J Pract Intern,2014,34(9):836-838.(in Chinese)郭晓钟,吴春燕.重视急性胰腺炎的病因诊断[J].中国实用内科杂志,2014,34(9):836-838.
    [10]YU W,WU W,ZHANG SH,et al.Progression of pathogenetic research of acute pancreatitis[J].Chin J Bases Clin General Surg,2006,13(6):733-736.(in Chinese)余文,吴伟,张少辉,等.急性胰腺炎发病机理的研究进展[J].中国普外基础与临床杂志,2006,13(6):733-736.
    [11]YANG XF,YANG ZY,ZHOU F,et al.Influence of prostaglandin E1 on cytokines and pancreatic pathology in rats with severe acute pancreatitis[J].Chin J Exp Surg,2006,23(1):112.(in Chinese)杨雪菲,杨智勇,周峰,等.前列腺素E1对大鼠重症急性胰腺炎细胞因子及胰腺病理的影响[J].中华实验外科杂志,2006,23(1):112.
    [12] XIE ML.Clinical efficacy of prostaglandin E1 in treatment of acute pancreatitis[J].Med Inf,2013,26(2):154.(in Chinese)谢梦玲.前列腺素E1治疗急性胰腺炎的临床疗效分析[J].医学信息,2013,26(2):154.
    [13]WANG LY.Clinical efficacy of prostaglandin E1 combined with Qingyi decoction in treatment of severe acute pancreatitis[J].China Prac Med,2013,8(23):146-147.(in Chinese)王丽娅.前列腺素E1联合清胰汤治疗重症急性胰腺炎的临床观察[J].中国实用医药,2013,8(23):146-147.
    [14]CHEN WJ,LIN SB.Effect of somatostatin combined wiith prostaglandin E1 on severe acute pancreatitis[J].Pract Pharm Clin Remed,2013,16(8):741-743.(in Chinese)陈文炯,林少斌.生长抑素联合前列腺素E1治疗重症急性胰腺炎的疗效观察[J].实用药物与临床,2013,16(8):741-743.
    [15]ZHAI XG,ZHANG ZH,ZHOU G,et al.Preliminary clinical study of somatostatin combined with prostaglandin E 1 in patients with severe acute pancreatits[J].Chongqing Med,2014,43(1):77-79.(in Chinese)瞿星光,张朝晖,周刚,等.生长抑素与前列腺素E1联合应用治疗重症急性胰腺炎初步临床研究[J].重庆医学,2014,43(1):77-79.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2154) PDF downloads(408) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return